Research Alliance Corporation IV (NASDAQ:RACD) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Alan A Musso Other companies: Rein Therapeutics, Inc. (Director · Since at least Oct 31, 2023); Fulcrum Therapeutics, Inc. (Chief Financial Officer · Since at least Aug 7, 2023); Bellicum Pharmaceuticals Inc (CFO and Treasurer · Dec 17, 2014 – Jul 2, 2018 · Past); Gyre Therapeutics, Inc. (SVP, Fin+Admin, CFO & Treas · Apr 11, 2006 – Oct 17, 2014 · Past) | Director · Since at least Jul 10, 2026 |
| Matthew Hammond Other companies: Research Alliance Corporation III (Chief Executive Officer, Director · Since at least May 19, 2026); Research Alliance Corp II (Chief Investment Officer, Director · Mar 17, 2021 – Mar 17, 2021 · Past); POINT Biopharma Global Inc (Chief Financial Officer, Director · Jul 7, 2020 – Jul 7, 2020 · Past) | Chief Executive Officer, Director · Since at least Jul 10, 2026 |
| Francis Sherman Adams Other companies: Research Alliance Corporation III (Chief Financial Officer · Since at least May 19, 2026) | Chief Financial Officer · Since at least Jul 10, 2026 |
| Henry Stusnick Other companies: Research Alliance Corporation III (COO and CBO · Since at least May 19, 2026) | COO and CBO · Since at least Jul 10, 2026 |
| John Michael Maslowski Other companies: Fibrocell Science Inc (CEO, Director · May 14, 2014 – Dec 13, 2019 · Past) | Director · Since at least Jul 10, 2026 |